Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Celularity

Celularity
2016 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$77.7M LATEST DEAL AMOUNT
13 INVESTORS
Description

Developer of therapies designed to treat autoimmune and degenerative diseases, immuno-oncology and functional regeneration. The company's therapies productize allogeneic cells and tissues derived from the postpartum placenta and have the ability to augment immunity and longevity by amplifying the body's ability to fight disease, heal and regenerate itself, enabling patients to begin treatment more quickly, resulting in a better medical outcome.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 33 Technology Drive
  • Warren, NJ 07059
  • United States

+1 (908) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Celularity’s full profile, request a free trial.

Celularity Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 09-Nov-2018 $77.7M 00000 Completed Generating Revenue
1. Early Stage VC (Series A) 15-Feb-2018 00000 00000 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Celularity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series X 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Celularity Competitors (56)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CytImmune Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00
0000000 0000000000 Venture Capital-Backed Indianapolis, IN 00 000.00 0000000000 0 000.00
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
000000000000 Venture Capital-Backed Houston, TX 000.00 00000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
To view this company’s complete list of competitors, request access »

Celularity Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 31-Aug-2018 000000000000000000 Laboratory Services (Healthcare) 000000 000000 00.0
0000000 0000000000 07-May-2018 000000000 00000 00 0000 Buildings and Property 000000 000000 00.0
HLI Cellular Therpaeutics 31-May-2017 Merger/Acquisition Biotechnology
To view this company’s complete investment and acquisition history, request access »

Celularity Subsidiaries (1)

Company Name Industry Location Founded
00000000 Laboratory Services (Healthcare) Irvine, CA 0000
To view this company’s complete subsidiary history, request access »

Celularity Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Castor Ventures Venture Capital Minority 000 0000 000000 0
Green D Ventures Venture Capital Minority 000 0000 000000 0
Alumni Ventures Group Venture Capital Minority 000 0000 000000 0
Andrew von Eschenbach Angel (individual) Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Celularity Executive Team (11)

Name Title Board
Seat
Contact
Info
Robert Hariri Ph.D Co-Founder, Chief Executive Officer & Chairman
Jay Kaminski Chief Operating Officer
John Haines Executive Vice President & Chief Administrative Officer
Steven French Chief Information Officer
Xiaokui Zhang Ph.D Executive Vice President & Chief Scientific Officer

1 Former Executive

You’re viewing 5 of 11 executives. Get the full list »

Celularity Board Members (11)

Name Representing Role Since Contact
Info
Andrew Pecora MD Self Board Member 000 0000
Andrew von Eschenbach MD Self Board Member 000 0000
Bill Maris Section 32 Board Member 000 0000
David Deming Self Board Member 000 0000
David Lemus Self Board Member 000 0000
You’re viewing 5 of 11 board members. Get the full list »